As seen in Fig. 2, treatment with QU + CIS resulted in increased expression of DLK, MAP3K4 (MEKK4), MAP2K4 (MEK4), CDC42 and MAPK8IP2/JIP1 (interacts with JNK1) genes on two-fold or more. Here, MAPK8IP2 is linked to in situ carcinoma.